A colloidal oatmeal OTC cream is as clinically effective as a prescription barrier repair cream for the management of mild to moderate atopic dermatitis in African American children

被引：0
|
作者：
Nunez, Christopher [1 ]
Hogan, Daniel [2 ]
Humphrey, Micah [2 ]
Zhang, Paul [1 ]
Lisante, ToniAnne [1 ]
Doshi, Uday [1 ]
机构：
[1] Johnson & Johnson Consumer Co Inc, Morris Plains, NJ USA
[2] Hill Top Res, St Petersburg, FL USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2013年 / 68卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB73 / AB73
页数：1
相关论文
共 33 条
  • [31] Randomized, controlled, double-blind clinical study evaluating the safety and efficacy of MD2011001 cream in mild-to-moderate atopic dermatitis of the face and neck in children, adolescents and adults
    Patrizi, Annalisa
    Raone, Beatrice
    Neri, Iria
    Gurioli, Carlotta
    Carbonara, Monica
    Cassano, Nicoletta
    Vena, Gino Antonio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (04) : 346 - 350
  • [32] Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial
    Simpson, Eric L.
    Eichenfield, Lawrence F.
    Papp, Kim A.
    Forman, Seth
    Hebert, Adelaide A.
    Gonzalez, Mercedes E.
    Gooderham, Melinda
    Hong, H. Chih-ho
    Prajapati, Vimal H.
    Guttman, Emma
    Silverberg, Jonathan
    Seal, Melissa
    Krupa, David
    Burnett, Patrick
    Synder, Scott
    Chu, David H.
    Higham, Robert C.
    Berk, David R.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 20 - 20
  • [33] Efficacy and safety of sequential topical 0.1% mometasone furoate cream and 2% crisaborole in the treatment of mild to moderate atopic dermatitis in children aged over 2 years-a multicentre parallel randomised controlled study in China
    Yang, Huan
    Shu, Hong
    Miao, Limin
    Li, Ping
    Wang, Shan
    Qian, Hua
    Chen, Zhenping
    Luo, Xiaoyan
    Ma, Lin
    Wang, Hua
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II1 - II1
1234